Skip to main content

2025 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Feng Li, Ph.D.

CSO
Crystal Formulation Services, China (People's Republic)

Poster(s):

(T1330-08-52) Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pediatric Clinical Trials

Tuesday, November 11, 2025
1:30 PM - 2:30 PM CT